Results 81 to 90 of about 4,484 (145)

Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting. [PDF]

Eur J Clin Microbiol Infect Dis
Pokorska-Śpiewak M, Dobrzeniecka A, Talarek E, Aniszewska M, Marczyńska M.   +4 more
europepmc   +1 more source

An eco-friendly chemometrics assisted UV spectrophotometric method for simultaneous determination of sofosbuvir, simeprevir and ledipasvir in pharmaceuticals. [PDF]

BMC Chem
Alshehri A, Alqahtani A, Alsayari A, Almrasy AA.   +3 more
europepmc   +1 more source

Exploring stationary phase morphologies as pathways to greener and faster LC for analyzing sofosbuvir and ledipasvir. [PDF]

Sci Rep
Ibrahim AE, Alamir SG, Salman BI, El Deeb S, Al-Harrasi A.   +4 more
europepmc   +1 more source

Health Disparities in Achieving Sustained Virologic Response Among Patients With Chronic Hepatitis C: A Retrospective Single-Center Study. [PDF]

Cureus
Leach E, Rana R, Nguyen C, Reinecke J, Hall A, Velagapudi M.   +5 more
europepmc   +1 more source

Generic <i>vs</i> brand forms of direct acting antivirals for hepatitis C virus treatment in Egyptian children. [PDF]

World J Hepatol
Mogahed E, Ghita H, Enayet A, Yasin N, El-Karaksy H.   +4 more
europepmc   +1 more source

A Database-Derived Global Overview of HCV Resistance-Associated Substitutions: Characterizing Genotypic, Regional, and Temporal Heterogeneity. [PDF]

Int J Mol Sci
Nunes GTM, Sant'Anna TBF, de Araujo NM.
europepmc   +1 more source

Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia. [PDF]

Viruses
Byambasuren A, Gyarvuulkhasuren B, Erdenebat B, Nyamdavaa K, Baatarkhuu O.   +4 more
europepmc   +1 more source

Mass balance study of [¹⁴C]Netanasvir Phosphate in healthy Chinese participants. [PDF]

Antimicrob Agents Chemother
Zhao C-y, Liu G-y, Qian L, Zhuang Y-l, Luo L, Zhang Y-j, Xie H-m, Zhu J, Li M, Chen Q, Liu Y, Jia J-y, Liu Y-m.   +12 more
europepmc   +1 more source

Safety and efficacy of different therapeutic regimens in Egyptian adults with moderate COVID-19 infection (EVEREST): a real-world retrospective study. [PDF]

Sci Rep
Abdel-Salam Elgohary M, Hamza N, Ali A, Zaher Abdel-Rahman R, Thabet Elnagar M, Emam Mohamed M, Seadawy MG, Zenhom Abdelfatah M, Taha NA, Rauof M, El-Bouseary MM.   +10 more
europepmc   +1 more source

Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Teymourzadeh E, Salesi M, Keshavarz K, Abyazi MA, Heiat M, Alavian SM.   +7 more
europepmc   +1 more source